'acute lymphocytic leukemia'

400mg Veenat Imatinib Tablet ₹ 1899 / Box Get Latest Price Packaging Type Box Manufacturer Natco Shelf Life 24 Months Dose/Strength 400 mg Brand Veenat Form Tablets Veenat 400 Tablet is used to treat several types of cancers. It is most commonly prescribed to treat blood cancers (chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumors. It works by targeting specific proteins that contribute to the growth and spread of cancer cells.

Dasatinib Tablet 100 Mg ₹ 2999 / Bottle Get Latest Price Product Brochure Strength 100 mg Pack Size 1*30 Tablet Pack Type Box Brand Name Sprycel Manufacturer BMS Usages chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia Country of Origin Made in India Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).[3] Specifically it is used to treat cases that are Philadelphia chromosome-positive (Ph+).[3] It is taken by mouth.[3] Common adverse effects include low white blood cells, low blood platelets, anemia, swelling, rash, and diarrhea.[3] Severe adverse effects may include bleeding, pulmonary edema, heart failure, and prolonged QT syndrome.[3] Use during pregnancy may result in harm to the baby.[3] It is a tyrosine-kinase inhibitor and works by blocking a number of tyrosine kinases such as Bcr-Abl and the Src kinase family.[3] Dasatinib was approved for medical use in the United States and in the European Union in 2006.[3][2] It is on the World Health Organization's List of Essential Medicines.[4]

Midostar Midostaurin 25mg Softgel Capsule - Rydapt ₹ 4444 / Box Get Latest Price Product Brochure Composition Midostaurin (25mg) Manufacturer Zydus Healthcare Ltd Packing 4 Capsule In A Strip Usage Acute myeloid leukemia (AML), systemic mastocytosis Strength 25 mg Product Name: Midostar 25mg Softgel Capsule Brand Name: Midostar, Rydapt, Midostaurin Composition: Midostaurin (25mg) Manufacturer/Marketer: Zydus Healthcare Ltd Packaging: To be provided (specify packaging details if available) Treatment: Acute myeloid leukemia (AML), systemic mastocytosis Product Description: Midostar 25mg Softgel Capsule contains Midostaurin, a kinase inhibitor used in the treatment of acute myeloid leukemia (AML) and systemic mastocytosis. It works by targeting specific proteins involved in cancer cell growth, helping to slow or stop the progression of the disease

Bdbrut 140mg Caps ₹ 2100 / Bottle Get Latest Price Product Brochure Form Tablet Usage/Application Personal Compostion Ibrutinib Prescription/Non prescription Non prescription Country of Origin Made in India Strength 140 mg Bdbrut Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy. Bdbrut Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. It may cause headache, diarrhea, and nausea as its side effects.USES OF BDBRUT CAPSULE Mantle-cell lymphoma Blood cancer (Chronic lymphocytic leukemia)

Calquency Acalaburtinib Capsules (Generic) ₹ 181765 / Bottle Get Latest Price Strength 100 mg Brand Calquency Acalaburtinib Composition Acalaburtinib Form Capsule Manufacture Natco Acalabrutinib is used to treat mantle cell lymphoma (MCL) in adults who have received at least one previous treatment for their cancer. This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This medicine is available only with your doctor's prescription

10mg CA Atra Softgel Capsules ₹ 3333 / Bottle Get Latest Price Packaging Size 100 Capsules Form Tablets Packaging Type Box Shelf Life 24 Months Strength 10 mg Brand CA Atra CA Atra 10 Softgel Capsule is a form of vitamin A. To treat blood cancer, it works by slowing the growth of certain types of diseased blood cells, and promotes the growth of normal, mature cells in the bone marrow and blood. This helps to treat blood cancer (acute promyelocytic leukemia).

140mg Nitib Ibrutinib Capsule ₹ 5999 / Bottle Get Latest Price Packaging Size 30 Capsules Packaging Type Box Form Tablets Shelf Life 24 Months Strength 140 mg Brand Nitib Nitib 140mg capsule, containing the active ingredient ibrutinib, is used to treat various blood cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia

ivermectin for humans 12mg Tablet ₹ 50 / Stripe Get Latest Price Strength 12mg Packaging Type Strip Prescription Required Yes Composition (Salts) Ivermectin Usages Covid 19 Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2 One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4 More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9 To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.

iveremectin Ivecop 6 Mg Tablet ₹ 35 / Stripe Get Latest Price Strength 6mg Packaging Type Strip Prescription Required Yes Composition (Salts) Ivermectin Usages Covid 19 Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been developed and distributed, major challenges remain regarding vaccine production and allocation.1 The identification of inexpensive, widely available, and effective therapies against Covid-19 is of great importance. The repurposing of existing medicines that are widely available and that have reasonably well understood safety profiles has appeal.2 One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites and has been shown to have clinical efficacy for the treatment of onchocerciasis, strongyloidiasis, and ectoparasitic infection (e.g., scabies).3 The in vitro antiviral activity of ivermectin has been explored against a spectrum of viruses, including severe acute respiratory syndrome coronavirus 1, human immunodeficiency virus, dengue virus, Zika virus, yellow fever virus, West Nile virus, Hendra virus, chikungunya virus, Semliki Forest virus, Sindbis virus, and avian influenza virus.4 More than 60 randomized trials of ivermectin for the treatment of Covid-19 have been registered, and findings have been reported for as many as 31 clinical trials.5 The results have been discordant, and various review groups interpret the evidence differently — some advocating for benefits of ivermectin, and others reticent to conclude a benefit.6-8 However, most trials have been small, and several have been withdrawn from publication owing to concerns about credibility.9 To evaluate the efficacy of ivermectin for the prevention of progression of Covid-19 resulting in hospitalization among outpatients with SARS-CoV-2 infection, we conducted a randomized, placebo-controlled, adaptive platform trial (TOGETHER) in the state of Minas Gerais, Brazil. Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.